v3.22.2.2
CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2022
Sep. 30, 2021
Current    
Cash and cash equivalents $ 149,157,861 $ 152,107,745
Incentive and tax receivables 3,192,580 9,136,831
Prepaid expenses and other current assets 354,162 371,914
Total Assets 152,704,603 161,616,490
Current Liabilities    
Accounts payable 3,824,777 4,739,781
Accrued liabilities (Note 3) 5,944,953 5,614,774
Deferred grant income (Note 4) 443,831 443,831
Total Liabilities 10,213,561 10,798,386
Capital stock Authorized:10,000,000 preferred stock, par value $0.001 per share
Capital stock Authorized: 200,000,000 common stock, par value $0.001 per share Issued and outstanding:77,942,568 common shares (September 30, 2021 - 75,918,465) 77,944 75,920
Additional paid-in capital 387,976,881 348,328,048
Accumulated deficit (245,563,783) (197,585,864)
Total Stockholders' Equity 142,491,042 150,818,104
Total Liabilities and Stockholders' Equity $ 152,704,603 $ 161,616,490